Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Olcun Umit UNAL"'
Autor:
Mehmet Uzun, Elif Atag, Eda Caliskan Yildirim, Murat Keser, Huseyin Salih Semiz, Olcun Umit Unal
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Biomarkers such as hormone receptors (HR) and human epidermal growth factor receptor2 (HER2) may change after neoadjuvant chemotherapy (NAC) in breast cancer patients. The aim of this study was to investigate the rates of receptor change aft
Externí odkaz:
https://doaj.org/article/d7ddd3ddd7f245d98d03a79420554f9d
Autor:
Olcun Umit Unal, Seval Akay, Huseyin Salih Semiz, Murat Keser, Gonul Demir, Zeliha Guzeloz Capar, Erkut Demirciler, Tugba Yavuzsen, Serkan Degirmencioglu, Bilgin Demir, Esin Oktay, Meltem Demirtas Gulmez, Mehmet Emin Arayici
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Background & aimsPrognostic factors of metastatic rectal cancer are not well known. We aim to determine prognostic factors affecting survival for metastatic rectal cancer patients and also to investigate the effect of tumor localization on overall su
Externí odkaz:
https://doaj.org/article/dfd37b3cc12c42648d63797f13af778a
Autor:
Eda Caliskan Yildirim, Elif Atag, Ezgi Coban, Olcun Umit Unal, Abdussamet Celebi, Murat Keser, Mehmet Uzun, Merve Keskinkilic, Eda Tanrikulu Simsek, Murat Sari, Tugba Yavuzsen
Publikováno v:
Breast, Vol 70, Iss , Pp 56-62 (2023)
Background: CDK4/6 inhibitors combined with endocrine therapy have significantly improved treatment outcomes for metastatic hormone receptor-positive (HR+) breast cancer patients. However, the impact of low HER2 expression on treatment response and p
Externí odkaz:
https://doaj.org/article/968ed83daa7545e0b6b5f0347defa3cf
Autor:
Seda Kahraman, Enes Erul, Mustafa Seyyar, Ozge Gumusay, Ertugrul Bayram, Burcin Cakan Demirel, Omer Acar, Sercan Aksoy, Naziyet Kose Baytemur, Elif Sahin, Devrim Cabuk, Gul Basaran, Semra Paydas, Arzu Yaren, Deniz Can Guven, Atike Pinar Erdogan, Umut Demirci, Alper Yasar, İbrahim Vedat Bayoglu, Mutlu Hizal, Burcu Gulbagci, Nail Paksoy, Sena Ece Davarci, Funda Yilmaz, Ozlem Dogan, Sibel Oyucu Orhan, Erkan Kayikcioglu, Ali Aytac, Merve Keskinkilic, Eda Eylemer Mocan, Olcun Umit Unal, Esra Aydin, Hakan Yucel, Deniz Isik, Onder Eren, Basak Oyan Uluc, Melike Ozcelik, Ilhan Hacibekiroglu, Adnan Aydiner, Hacer Demir, Berna Oksuzoglu, Ebru Cilbir, Erdem Cubukcu, Bulent Cetin, Esin Oktay, Cihan Erol, Sadi Kerem Okutur, Nilgun Yildirim, Ali Alkan, Fatih Selcukbiricik, Asude Aksoy, Yusuf Karakas, Gulhan Ozkanli, Berna Bozkurt Duman, Dincer Aydin, Ozgecan Dulgar, Muhammed Muhiddin Er, Fatih Teker, Tugba Yavuzsen, Musa Baris Aykan, Ali Inal, Yakup Iriagac, Nurhan Onal Kalkan, Murat Keser, Teoman Sakalar, Serkan Menekse, Engin Kut, Burak Bilgin, Muge Karaoglanoglu, Veli Sunar, Ozlem Ozdemir, Nazim Serdar Turhal, Nuri Karadurmus, Bulent Yalcin, Mehmet Ali Nahit Sendur
Background: Ribociclib, palbociclib and abemaciclib are currently approved CDK4/6 inhibitors along with aromatase inhibitors as the first-line standard-of-care for patients with hormone receptor-positive, HER2-negative metastatic breast cancer. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af4603b0dea982cdc71feb0666817cb5
https://avesis.deu.edu.tr/publication/details/6b4454d1-de76-4c63-9dab-2c0deccc7b07/oai
https://avesis.deu.edu.tr/publication/details/6b4454d1-de76-4c63-9dab-2c0deccc7b07/oai
Autor:
Ahmet Bilici, Sinan Koca, Mustafa Karaagac, Sabin Goktas Aydin, Emrah Eraslan, Muhammed Ali Kaplan, Birol Ocak, Sema Sezgin Goksu, Semra Paydas, Fahri Akgul, Sumeyye Derin, Yakup Ergun, Emre Yekeduz, Cihan Erol, Deniz Tataroglu Ozyukseler, Atike Gokcen Demiray, Mustafa Karaca, Zeynep Gulsum Guc, Serkan Menekse, Havva Yesil Cinkir, Ozge Gumusay, Abdullah Sakin, Ozlem Ozkul, Hacer Demir, Dilek Erdem, Mehmet Besiroglu, Olcun Umit Unal, Ramazan Acar, Lokman Koral, Suleyman Sahin, Teoman Sakalar, Aykut Bahceci, Ahmet Ozveren, Ulug Mutlu Gunaydin, Mehmet Metin Seker, Veli Sunar, Pinar Dal, Mehmet Artac, Serdar Turhal
Aim: Description of patient characteristics, effectiveness and safety in Turkish patients treated with pazopanib for metastatic soft tissue sarcoma (STS). Patients and methods: This multicenter study is based on retrospective review of hospital medic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e475dde06decc907f161d14d4d0f2ae4
https://avesis.deu.edu.tr/publication/details/c895112d-5502-4614-a59b-a819d23aebc3/oai
https://avesis.deu.edu.tr/publication/details/c895112d-5502-4614-a59b-a819d23aebc3/oai
Objective: It is important to evaluate the nutrition of patients in palliative care centers. Most patients are unrecognized and lacking treatment, as there is no consensus on ways to scan, diagnose, treat and follow the malnutrition, and the lack of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c20bc3ef8170c3beccddc1ec4212e85
https://avesis.deu.edu.tr/publication/details/d846d36f-2d4a-4806-b693-6a5110012b22/oai
https://avesis.deu.edu.tr/publication/details/d846d36f-2d4a-4806-b693-6a5110012b22/oai
Publikováno v:
Dicle Medical Journal, Vol 46, Iss 3, Pp 567-573 (2019)
Background: Gastric cancer is responsible for a considerable proportion of all cancer-related deaths. Elderly cancer patients are often ignored in prospective studies in which the efficacy of chemotherapy is evaluated, although more than half of all
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1078b9ef95c4e994b0ace346196d440
Autor:
Serkan Degirmencioglu, Ilker Kiraz, Gamze Gokoz Dogu, Arzu Yaren, Atike Gökçen Demiray, Halil Serdar Aslan, Esin Oktay, Burcu Yapar Taskoylu, Ergin Sagtas, Muhammet Arslan, Olcun Umit Unal
Publikováno v:
Acta Oncologica Turcica. 52:203-207
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::856d14c1f38cef96a6d2fe99f08ff227
https://doi.org/10.5505/aot.2019.30932
https://doi.org/10.5505/aot.2019.30932
Autor:
Ilkay Tugba Unek, Gönül Demir, Mustafa Emiroglu, Naciye Ümit Bayol, Harun Akar, Hülya Ellidokuz, Asım Leblebici, Olcun Umit Unal, Fatma Özkan
Publikováno v:
The journal of Tepecik Education and Research Hospital.
Objective: The overexpression of human epidermal growht factor-2 (HER-2) receptor is detected in 20% of patients with breast cancer. The prognosis is poor in patients with HER-2(+) breast cancer not receiving systemic therapy. Modified lymph node rat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9df18f833b183515c11f43e8022901e6
https://doi.org/10.5222/terh.2021.92259
https://doi.org/10.5222/terh.2021.92259
Publikováno v:
Colon Polyps and Colorectal Cancer ISBN: 9783030572723
Colorectal cancer is the third most common type of cancer in the world. Relapse and death due to relapse develop in approximately half of the patients after curative resection in colon cancer. Adjuvant therapy is recommended to reduce relapses. Adjuv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a774cf1fbc5e7751785defcc96b1cebe
https://doi.org/10.1007/978-3-030-57273-0_34
https://doi.org/10.1007/978-3-030-57273-0_34